Shred Protocol
Targeted fat loss and body recomposition while preserving lean muscle mass
Peptide Stack
Preparation
Reconstitute all peptides with bacteriostatic water. CJC-1295 and Ipamorelin can be mixed together. Fragment 176-191 should be kept separate. Store at 2-8°C and use within 2-4 weeks.
Administration
Morning (fasted): Fragment 176-191, then CJC/Ipa 15 minutes later. Pre-workout: Fragment 176-191. Before bed: CJC/Ipa. Always inject on empty stomach for Fragment 176-191. Rotate injection sites.
Monitoring
Track body weight, body fat percentage, waist circumference, and progress photos weekly. Monitor energy levels and workout performance. Most users see measurable fat loss by week 3-4.
Expected Timeline
Week 1-2: Improved metabolism and energy. Week 3-6: Noticeable fat loss, especially abdominal area. Week 7-12: Continued fat reduction and muscle definition. Best results with caloric deficit and regular exercise.
Research Basis
Fragment 176-191 is a modified fragment of human growth hormone that specifically targets fat metabolism without affecting blood sugar. Combined with GH optimization (CJC/Ipa), this protocol provides both direct lipolytic effects and improved overall metabolism.
Safety Considerations
- Do not use if you have active cancer
- Avoid during pregnancy or breastfeeding
- Monitor blood glucose levels
- Maintain adequate protein intake to preserve muscle
- Consult with a healthcare professional before starting
- This protocol is for research and educational purposes only
Protocol Overview
A targeted fat loss protocol combining GH optimization with the lipolytic Fragment 176-191. The GH base improves overall metabolism while Frag 176-191 directly stimulates fat oxidation without affecting blood sugar.
Duration: 12 weeks Peptides: 3 Experience Level: Beginner
Peptide Stack
CJC-1295-NO-DAC
- Dose: 100 mcg
- Frequency: twice daily
- Timing: morning and before bed
IPAMORELIN
- Dose: 100-200 mcg
- Frequency: twice daily
- Timing: with CJC-1295 doses
FRAGMENT-176-191
- Dose: 250-500 mcg
- Frequency: twice daily
- Timing: morning (fasted) and pre-workout
Preparation
Reconstitute all peptides with bacteriostatic water. CJC-1295 and Ipamorelin can be mixed together. Fragment 176-191 should be kept separate. Store at 2-8°C and use within 2-4 weeks.
Administration
Morning (fasted): Fragment 176-191, then CJC/Ipa 15 minutes later. Pre-workout: Fragment 176-191. Before bed: CJC/Ipa. Always inject on empty stomach for Fragment 176-191. Rotate injection sites.
Monitoring
Track body weight, body fat percentage, waist circumference, and progress photos weekly. Monitor energy levels and workout performance. Most users see measurable fat loss by week 3-4.
Expected Timeline
Week 1-2: Improved metabolism and energy. Week 3-6: Noticeable fat loss, especially abdominal area. Week 7-12: Continued fat reduction and muscle definition. Best results with caloric deficit and regular exercise.
Research Basis
Fragment 176-191 is a modified fragment of human growth hormone that specifically targets fat metabolism without affecting blood sugar. Combined with GH optimization (CJC/Ipa), this protocol provides both direct lipolytic effects and improved overall metabolism.
Safety Considerations
- Do not use if you have active cancer
- Avoid during pregnancy or breastfeeding
- Monitor blood glucose levels
- Maintain adequate protein intake to preserve muscle
- Consult with a healthcare professional before starting
- This protocol is for research and educational purposes only
Disclaimer: This protocol is for educational and research purposes only. It is not medical advice. Consult with a qualified healthcare professional before starting any peptide protocol. These compounds are not approved by the MHRA for human therapeutic use.
Important Disclaimer: This protocol is for educational and research purposes only. It is not medical advice. Consult with a qualified healthcare professional before starting any peptide protocol. These compounds are not approved by the MHRA for human therapeutic use.